SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19

The unprecedented global COVID-19 pandemic has prompted a desperate international effort to accelerate the development of anti-viral candidates. For unknown reasons, COVID-19 infections are associated with adverse cardiovascular complications, implicating that vascular endothelial cells are essentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Nader, Danielle, Fletcher, Nicola, Curley, Gerard F., Kerrigan, Steven W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221465/
https://www.ncbi.nlm.nih.gov/pubmed/34161337
http://dx.doi.org/10.1371/journal.pone.0253347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221465/
https://www.ncbi.nlm.nih.gov/pubmed/34161337
http://dx.doi.org/10.1371/journal.pone.0253347

Ejemplares similares